Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
- 1 October 1991
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (19) , 8539-8543
- https://doi.org/10.1073/pnas.88.19.8539
Abstract
A brief (30 min) treatment of mouse peritoneal cells (mixture of nonadherent lymphocytes and adherent macrophages) with 1-20 micrograms of lysophosphatidylcholine (lyso-PC) per ml in serum-supplemented RPMI medium 1640, followed by a 3-hr cultivation of the adherent cells alone, results in a greatly enhanced Fc receptor-mediated phagocytic activity of macrophages. This rapid process of macrophage activation was found to require a serum factor, the vitamin D3 binding protein (the human protein is known as group-specific component; Gc). Efficient activation of macrophages was achieved by using medium containing purified human Gc protein. Analysis of intercellular signal transmission among nonadherent (B and T) cells revealed that lyso-PC-treated B cells modify Gc protein to yield a proactivating factor, which can be converted by T cells to the macrophage-activating factor. This rapid generation process of the macrophage-activating factor was also demonstrated by stepwise incubation of Gc protein with lyso-PC-treated B-cell ghosts and untreated T-cell ghosts, suggesting that Gc protein is modified by preexisting membranous enzymes to yield the macrophage-activating factor. Incubation of Gc protein with a mixture of beta-galactosidase and sialidase efficiently generated the macrophage-activating factor. Stepwise incubation of Gc protein with B- or T-cell ghosts and sialidase or beta-galactosidase revealed that Gc protein is modified by beta-galactosidase of B cells and sialidase of T cells to yield the macrophage-activating factor. Administration to mice of a minute amount (4-10 pg per mouse) of in vitro, enzymatically generated macrophage-activating factor resulted in a greatly enhanced (3- to 7-fold) ingestion activity of macrophages.Keywords
This publication has 19 references indexed in Scilit:
- A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytesImmunology & Cell Biology, 1990
- Contribution of Lysophosphatidylcholine-Treated Nonadherent Cells to Mechanism of Macrophage ActivationExperimental Biology and Medicine, 1990
- Activation process of macrophages afterin vitrotreatment of mouse lymphocytes with dodecylglycerolClinical and Experimental Immunology, 1990
- Activation of macrophages by ether analogues of lysophospholipidsCancer Immunology, Immunotherapy, 1987
- Activation of peritoneal macrophages by lysophosphatidylcholineBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- Activation of T lymphocytes results in an increase inH-2-encoded neuraminidaseImmunogenetics, 1985
- Isolation and characterization of the O-glycan chain of the human vitamin-D binding proteinBiochemical and Biophysical Research Communications, 1983
- Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component)Archives of Biochemistry and Biophysics, 1983
- Neuraminidase deficiency in the mouseFEBS Letters, 1979
- Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.The Journal of Experimental Medicine, 1975